Literature DB >> 8796214

Reverse sequestration in a case of sickle crisis.

E S Lee1, P C Chu.   

Abstract

A patient with homozygous sickle cell disease presented with sickle crisis complicated by hepatic and pulmonary sequestration and required intensive therapy. During the recovery phrase she developed a rapid rise of haemoglobin concentration, unrelated to blood transfusion, followed by hypertension, congestive cardiac failure and catastrophic intracerebral haemorrhage. This serious haemodynamic disturbance was considered to be caused by a reversal of the sequestration process. Careful monitoring of a sickle cell patient's blood pressure, blood counts, haematocrits, haemoglobin S level and plasma viscosity, even after the end of a sequestration crisis, is recommended.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796214      PMCID: PMC2398548          DOI: 10.1136/pgmj.72.850.487

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

Review 1.  Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Authors:  K Ohene-Frempong
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

2.  Neurologic events after partial exchange transfusion for priapism in sickle cell disease.

Authors:  W R Rackoff; K Ohene-Frempong; S Month; J P Scott; B Neahring; A R Cohen
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

3.  Hypertension, convulsions, and cerebral haemorrhage in sickle-cell anaemia patients after blood-transfusions.

Authors:  J E Royal; R A Seeler
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

4.  Incidence of overt and covert neurological damage in children with sickle cell disease.

Authors:  P C Hindmarsh; M Brozovic; C G Brook; S C Davies
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

  4 in total
  5 in total

Review 1.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

2.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

3.  Time to rethink haemoglobin threshold guidelines in sickle cell disease.

Authors:  Samir K Ballas; Frans A Kuypers; Victor R Gordeuk; Jane S Hankins; Alexis A Thompson; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2021-06-15       Impact factor: 8.615

Review 4.  Sickle Hepatopathy.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2020-08-09

Review 5.  Acute and chronic hepatobiliary manifestations of sickle cell disease: A review.

Authors:  Rushikesh Shah; Cesar Taborda; Saurabh Chawla
Journal:  World J Gastrointest Pathophysiol       Date:  2017-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.